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Abstract 
 
 Cells become different in development due to induction, a ligand-mediated cell 
interaction.  This type of interaction is an area of intense research for developmental biologists 
studying the effects of different growth factors (during development). The conventional approach 
to induction with Xenopus Laevis, African Clawed Frog, employs placing cells or tissues in a 
growth factor solution.  This design reveals an enormous amount of information and insight into 
developmental processes, but it is not an accurate approach to simulate in vivo conditions.  Here, 
I use a novel approach, termed solid-phase induction, as a more realistic and controllable 
approach.  I utilize a glass surface coated with fibrin to act as a surface to adhere growth factors 
for Solid-phase presentation.  This method will not only provide a more accurate representation 
of cell-cell inductions, but will also add an increased level of control in presenting growth 
factors.  This approach will be used to answer developmental questions that involve spatially 
oriented induction and differential induction by different concentration gradients or specific 
patterns of a number of growth factors.  
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Introduction 
I. Signal Transduction: 
 Signal transduction refers to the passage of a signal from the outside of the cell to 
the inside of the cell.  There are many different types of signal transduction events, and 
can be as simple as a ligand binding to its receptor allowing the passage of molecules 
through a membrane channel.  Some signal transduction events can be very complex, 
for example where the ligand-receptor complex initiates the phosphorylation of a 
number of proteins inside the cell.   
 During embryonic development, many signals are used in patterning, migration 
and differentiation.  These signals must have a specific means to act on their intended 
cells.  Signal transduction is one way in which this is possible.  Cells must contain all 
the elements of the signal transduction cascade to be able to elicit the specific response 
intended by the ligand.   
 There are five main signal transduction pathways that are utilized during 
development: 1) the receptor tyrosine kinase (RTK) pathway, 2) the Smad pathway, 3) 
the JAK-STAT pathway, 4) the Wnt pathway, and 5) the Hedgehog pathway (Gilbert, 
2000).  The RTK pathway is activated by binding of a specific ligand or a small class 
of ligands per receptor.  Some of these ligands are members of the Fibroblast Growth 
Factor (FGF) family (Dailey et al., 2005), the Endothelial Growth Factor (EGF) 
family, and the Platelet Derived Growth Factor (pDGF) family.  Binding of the ligand 
causes the receptors to form a homodimer which activates the intracellular domain by 
autophosphorylation.  Once phosphorylated an adaptor protein binds and then activates 
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a powerful intracellular transducer, a G-protein.  The rest of the cascade of events 
depends on the cell being signaled and the ligand that was delivered (Gilbert, 2000).  
Some of the developmental processes driven by this signaling cascade include 
proliferation, growth arrest, differentiation or apoptosis (Dailey et al., 2005). 
 The next class is the Smad pathway.  Activation is initiated by binding of a 
member of the transforming growth factor- β (TGF-β) family to a type II TGF-β 
receptor, which forms a heterodimer with a type I receptor (Gilbert, 2000).  Once 
again, autophosphorylation takes place but on a serine or threonine residue.  After 
activation, the type I receptor activates the Smad proteins by phosphorylation (Shi and 
Massague, 2003).  Members of the bone morphogenic protein (BMP) family activate 
the Smad 1 and 5 proteins, while activin and other members of the TGF-β family 
activate the Smad 2 and 3 proteins.  In both cases, these Smad proteins will form a 
transcription factor complex with Smad 4 to enter the nucleus (Gilbert, 2000).   
 The JAK-STAT signal transduction pathway is named after its transcription 
factors, the signal transducers and activators of transcription, or STATs.  They are 
commonly activated by being phosphorylated from the FGF receptors and the JAK 
family of tyrosine kinases after binding by a variety of cytokines, hormones and 
growth factors (Valentino and Pierre, 2006).  This signal transduction pathway is very 
important in the differentiation of blood cells, regulation of fetal bone growth, and 
others (Gilbert, 2000).    
 The proteins of the Wnt family are  paracrine factors that bind and activate the 
transmembrane receptors of the Frizzled family (Gilbert, 2000).  The Frizzled proteins 
frequently activate the protein Disheveled which inhibits glycogen synthase kinase-3.  
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This is only one possible pathway, but there are many different roads that this 
transduction pathway can take depending on the proteins present in the cell.  The Wnt 
pathway is commonly activated to turn on  specific Wnt activated genes during 
development, to control actin and microtubular growth, as well as to release of Ca+ 
from the endoplasmic reticulum (Gilbert, 2000).  The regulation of Wnt signaling has 
also been implicated in the important early developmental process that initiates cardiac 
development (Eisenberg and Eisenberg, 2006). 
 The final signal transduction pathway is the Hedgehog pathway.  The proteins of 
the hedgehog family are of fundamental importance during development as well as 
maintaining tissue patterns in adult organisms (Bijlsma et al., 2004).  These proteins 
are paracrine factors that bind to the membrane receptor Patched (Ptc.) (Bijlsma et al., 
2004).  However, Ptc. is not a signal transducer itself, but rather it is attached to one, 
Smoothened (Smo.).  When bound to Ptc, Smo is inactive.  The inhibition of Smo 
subjects a zinc finger transcription factor to remain tightly contained in a microtubule-
bound protein complex. While in this complex the N-terminal region of the 
transcription factor will be subject to cleavage.  This cleaved portion of the 
transcription factor acts as a repressor and enters the nucleus to inhibit transcription of 
hedgehog specific genes (Bijlsma et al., 2004).  Once a hedgehog member is bound to 
Ptc the Smo protein is released.  This will in turn allow for the removal of the zinc 
finger transcription factor from the microtubule-bound complex leading to hedgehog 
specific gene transcription (Bijlsma et al., 2004).  This pathway is involved in many 
developmental processes but is imperative during vertebrate limb and neural 
differentiation (Gilbert, 2000).   
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II. Xenopus Early Development: 
 Development of Xenopus laevis, the African clawed frog, begins with early 
patterning and formation of the embryo.  This process is very intricate with multiple 
signals working together to direct differentiation as well as shaping and migration of 
the tissues into their proper orientation.  This initial harmonious organization by 
multiple signaling events leads to the development of specialized organs and body 
structures that work together as the blueprint of the adult organism.   
 In the early developing embryo, the first example of this precise molecular 
signaling is the specification of the embryonic germ layers.  The establishment of these 
germ layers entails the following: cellular asymmetries, inductive interactions, 
maternal factors, and mechanical movements (Shook et al., 2004).  Each germ layer 
arises as disparate cell populations, within the embryo, with ectoderm at the top of the 
embryo, endoderm at the bottom of the embryo, and mesoderm between the two 
(Fig.1) (Shook et al., 2004).  The allocation of each germ layer is so precise that the 
proportion of each is consistent from individual to individual (Wardle and Smith, 
2004).   
 
Fig. 1 Germ Layer Orientation.  
Initial orientation of the three germ layers at the blastula stage of Xenopus 
development (Fig. 10.21A from Gilbert, 2000 by permission from Sinauer Inc). 
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 Once the three germ layers are set up, the embryo undergoes the process of 
gastrulation (Fig. 2).  During gastrulation the three germ layers migrate to their final 
positions with the ectoderm lining the outer surface of the embryo and the mesoderm 
and endoderm to the inside of the embryo (Maurus and Kuhl, 2004).  This 
rearrangement initiates most of the inductive events of the embryo that will lead to the 
formation of the adult organism.  It also leads to the transformation of a spherical 
embryo to one that is elongated along the anterior-posterior axis (Maurus and Kuhl, 
2004).   
 
 
 
Fig. 2 Gastrulation of Xenopus Embryo.  
Detailed depiction of the movements that take place during Xenopus gastrulation.  The 
diagram begins with an embryo in the blastula stage where the three germ layers are 
already set up.  The process of gastrulation is the initial migration and differentiation 
of the cells of the embryo to set up the future body plan of the embryo from the initial 
three germ layers. 
(Fig. 10.7 from Gilbert, 2000 by permission from Sinauer Inc) 
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III. Xenopus tissue induction: 
 The actual process of induction was well described by Pander in 1817, “each 
germ layer is not yet independent enough to indicate what it truly is; it still needs the 
help of its sister travelers, and therefore, although already designated for different 
ends, all three influence each other collectively until each has reached and appropriate 
level.”  Today, this process being described by Pander can be termed induction.   
 During Xenopus development, there are many examples of induction.  Some of 
the most well known examples include neural induction, midbrain-hindbrain induction, 
dorsal and ventral fin induction, limb organogenesis and mesoderm induction.   
 Once the three germ layers have been set up in the early Xenopus embryo the 
process of gastrulation takes place where cells from the surface invaginate through the 
blastopore and migrate underneath the ectoderm.  In 1924, Hilde Mangold, a student of 
Hans Spemann, established the concept that neural induction took place with the 
interactions of the dorsal lip of the blastopore and the overlying ectoderm during 
gastrulation (Stern, 2005).  This dorsal lip would later be called the Spemann 
organizer.  In the 1990’s, three genes coding for proteins that had neuralizing activity 
were found to emanate from the organizer, Noggin, Follistatin, and Chordin (Smith et 
al., 1993), (Hemmati-Brivanlou et al., 1994), (Sasai et al., 1995).  These molecules 
were BMP binding proteins, and once bound would block the action of BMP with the 
BMP receptor (Piccolo et al., 1996).  These findings led to the default mode of neural 
induction where the inherent ability of the ectoderm to differentiate into neural tissue is 
inhibited by BMP (Hemmati-Brivanlou and Melton, 1997).  This has been the current 
understanding of neural induction since then, but recent evidence indicates that other 
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molecules such as the FGFs, are also necessary for neural induction (Stern, 2005).  It is 
clear that there are multiple different signaling molecules and transcription factors that 
must be coordinated not only in a spatial arrangement but also in a concentration 
dependent manner for neural induction to take place.   
 Once neural induction has commenced, this neural tissue must be further 
differentiated into the multiple neural fates.  Tissue that has been induced to 
differentiate to a neural fate in response to noggin or chordin shows only anterior 
specification leading to the idea that these factors alone are not sufficient to pattern the 
newly formed neural tissue (Song et al., 1999).  Although little is known about the 
specifics of neural patterning, there are two canadates, xGCNF, a nuclear orphan 
receptor is a good candidate for neural patterning, and retinoic acid (RA) (Song et al., 
1999; van der Wees et al., 1998).  xGCNF shows an expression pattern and activity 
that can be reliably linked to the patterning of the midbrain-hindbrain region (Song et 
al., 1999).  The second candidate, RA, has been shown to have a dramatic affect on 
hindbrain formation.  If there is too much RA present or the retinoic acid receptors are 
over expressed there is a dramatic increase in the volume of the hindbrain (van der 
Wees et al., 1998).   
 In Xenopus, development of a dorsal/ventral fin provides the means for tadpole 
locomotion, prior to the formation of the limbs.  This fin begins to develop at the tail 
bud stage along the trunk and tail of the embryo (Tucker and Slack, 2004).  Both the 
dorsal and ventral portions of the fin consist of mesenchyme derived from neural crest 
cells.  Not only do these neural crest cells provide the mesenchyme that make up the 
fin, but they are also responsible for the induction of the epidermis of the fin (Tucker 
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and Slack, 2004).  This induction is restricted to the dorsal half of the fin whereas the 
ventral half is receiving its induction via a different source (Tucker and Slack, 2004).  
Although the specific molecules involved in this inductive process are unknown at 
present, this is another example of a single tissue being induced differentially by 
distinct sources of molecules interacting with in an individual tissue.   
 The inductive process of limb initiation and outgrowth in other organisms has 
been centered on the interactions of two FGF molecules in these tissues.  FGF-10 is 
expressed in the mesenchyme which induces the expression and maintenance of FGF-8 
in the surrounding limb bud ectoderm.  In turn, FGF-8 also feeds back to maintain the 
expression of FGF-10 in the mesenchyme to allow for limb outgrowth (Martin, 1998).   
 Limb development has been an understudied area in Xenopus because of the late 
onset during development.  Recently however, this topic has received more attention 
because of the implications of limb regeneration.  Xenopus has an ability to regenerate 
its limbs during a period of its development.  The developing limb is primarily 
composed of mesenchymal tissues derived from the lateral plate mesoderm with a 
surrounding layer of ectoderm.  It has been shown that FGF-10 soaked beads, 
introduced to this mesenchyme, will initiate limb formation (Yokoyama et al., 2001).  It 
is hypothesized that limb development in the Xenopus is driven by the interactions of 
FGF molecules as well.   Once again, here is an inductive process that integrates more 
than one signaling molecule to allow, in this case, the development of the limb.  
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IV. Mesoderm Induction: 
 One of the most well studied induction events is that of mesoderm tissue.  To set 
up the initial three germ layers (ectoderm, mesoderm, and endoderm (Fig. 2)) the 
mesoderm in the early embryo must be induced.  Mesoderm induction happens right 
before gastrulation in the Xenopus embryo, and represents the first cell-cell interaction 
(Eimon and Harland, 2002).  The induction of this tissue stems from the interactions 
between the ectoderm and the endoderm.  This interaction was shown through 
recombinant experiments performed by Slack (1991) where blastula embryos were 
dissected and sandwiches were made with vegetal pole explants (prospective 
endoderm) and animal caps (prospective ectoderm).  Slack concluded that the ectoderm 
was induced to form mesoderm through endodermal signaling.   
 Through the years, there have been many candidate ligands for this induction such 
as bFGF, Activin, Derriere, and Xenopus nodal related (Slack, 1991; Smith et al., 1995; 
Sun et al., 1999; Thomsen and Melton, 1993).  More recent research has lead to the 
discovery that there is a maternally encoded transcript that must be present to generate 
the production of this mesoderm-inducing signal.  This maternal transcription factor, 
VegT, is localized in the vegetal cortex of the oocyte.  When inhibited in 
oligonucleotide depletion experiments, there was an inhibition of mesoderm signaling 
and formation (Zhang et al., 1998).  Kofron et al. (1999) hypothesized that VegT must 
be responsible for promoting the expression of the natural in vivo mesoderm inducer.  
Indeed VegT directly regulates the expression of Derriere and Xnr4 in the Xenopus 
embryo (Kofron et al., 1999; Yasuo and Lemaire, 1999).  Both the Xnrs and Derriere 
act as molecular morphogens, eliciting a full range of mesoderm inductions in a dose 
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dependent mannor (Schier and Shen, 2000).  Even though bFGF and Activin may play 
roles in mesoderm formation, there has been a shift in thinking towards the Xnrs and 
Derriere as the natural mesoderm inducers.  This new idea is based on the results that 
they both act as gradient dependent mesoderm inducers and most importantly, that their 
expressions are regulated by the maternally encoded VegT RNA.   
 
V. FGF as a mesoderm signaling molecule: 
 In 1987, Slack and colleagues discovered the first mesoderm inducer, basic FGF 
(Slack et al., 1987).  Once word spread of the first mesoderm inducer being bFGF, the 
scientific community considered this to be a good candidate as the endogenous 
mesoderm-inducing signal in Xenopus (Isaacs et al., 1994).  This was not a blind idea 
because it had an evolutionary background.  bFGF signaling is required for mesoderm 
induction in the vertebrates,  mouse and zebrafish, as well as the primitive chordate 
Ciona (Nishida, 2002).   
 The FGFs constitute a family of peptide growth factors that after binding to their 
tyrosine kinase receptors, induce receptor dimerization and autophosphorylation of 
intracellular tyrosine residues (Mohammadi et al., 1996).  One of the consequences of 
receptor autophosphorylation is to activate the GTPase Ras, setting off a cascade of 
kinases including Raf, MEK, and finally MAPK which ultimately results in processes 
such as the induction of gene expression required in mesoderm induction in Xenopus 
(Fambrough et al., 1999).   
 bFGF expression is only seen in a small region between the ectoderm and 
endoderm (Smith, 1989).  bFGF was ruled out as the primary, vegetal-localized 
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mesoderm inducer because they were only localized to the early mesoderm ring, and 
then later around the blastopore.   
 Further research has led biologists to believe that bFGFs role in mesoderm 
formation is that of a competence factor (Bottcher and Niehrs, 2005).  bFGF must be 
present in the prospective mesoderm to allow for the full range of mesoderm induction 
via the primary mesoderm inducers.  This has been demonstrated by knocking out the 
bFGF receptor as well as over expressing the receptor.  When activin or the Xnrs were 
introduced to animal caps that had altered bFGF receptors, mesoderm induction was 
interrupted (Cornell and Kimelman, 1994).  Once the Xnrs act on the presumptive 
mesoderm tissue, a T-box transcription factor, Xbra is expressed (Cornell and 
Kimelman, 1994; Loose and Patient, 2004).  It is now believed that this expression of 
Xbra is responsible for the expression of FGF in the presumptive mesoderm of the 
marginal zone.  Once FGF expression is present, it maintains the expression of Xbra 
(Schulte-Merker and Smith, 1995).  This feedback loop is necessary for proper 
mesoderm induction.  
 
VI. Definition of solid-phase: 
 To date, most of these developmentally important signaling molecules have been 
assayed using Xenopus animal caps and liquid-phase growth factors.  The Xenopus 
embryo is allowed to develop to stage 9 (Nieuwkoop, 1956), and then the ectoderm 
(animal cap) is removed (Fig. 3).  This tissue is capable of being induced into multiple 
tissue lineages depending on the growth factor presented.  Once the caps have been 
isolated they are cultured in a liquid-phase growth factor solution and then assayed for 
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tissue specific gene expression.  The term “liquid-phase” refers to soluble, freely 
diffusible signaling molecules.  In contrast, the term “solid-phase” refers to the 
immobilization of a signaling molecule to a matrix (Campbell and Andress, 1997; 
Campbell and Andress, 1997; Campbell et al., 1999; Campbell et al., 1994; Durham et 
al., 1999; Fan et al., 2000; Sakiyama-Elbert and Hubbell, 2000; Sakiyama-Elbert and 
Hubbell, 2000).  There are multiple ways to immobilize a signaling molecule to a 
matrix, but they can be grouped into two broad categories: (1) adsorption via non-
specific protein-protein interactions (2) highly specific adsorbtion with high affinity 
interactions, such as heparin binding domains.  The ability of these signaling molecules 
to remain bound to the matrix depends on the binding affinity, number of binding sites, 
and the presence of competitive binding molecules.  Two of the methods to being 
utilized to immobilize the signaling molecules are: (1) by directly pipetting the desired 
growth factor to the fibrin coated glass slide and allowing it to dry, or (2) printed 
patterns deposited with a custom inkjet system that was developed for precise printing 
applications.  This inkjet is a MicroJetTM piezoelectric drop-on-demand device with a 
30um diameter nozzle (MicroFab Technologies, Inc., Plano, TX) (Campbell et al., 
2005).  
 The bioavailability of FGF-2 and response of human MG-63 cells to the printed 
pattern have previously been demonstrated (Campbell et al., 2005).  The presence of 
printed FGF-2 does not alter its attachment to human MG-63 cells prior to their 
response to the growth factor (Campbell et al., 2005).  These cells proliferate, the 
expected response to FGF-2, when seeded on the solid-phase printed FGF-2 (Miller et 
al., 2006). 
 19 
VII. Rationale for engineering solid-phase spatial patterns of hormones 
on fibrin and fibronectin matrices: 
 Solid-phase presentation of signaling molecules, rather than liquid-phase, is of 
biological relevance, since endogenous solid-phase extracellular hormone gradients are 
present in an array of developmental models (Gurdon and Bourillot, 2001; Ruhrberg et 
al., 2002, Strigini and Cohen, 2000).  This solid-phase approach is plausible because 
many signaling molecules bind to extra cellular matrices (ECM), either directly or 
through intermediate binding proteins (Rifkin et al., 1999).  Persistent patterns can be 
set up by sequestering signaling molecules in the ECM to control their spatial 
arrangement.  An example is proteoglycans, a class of ECM and cell surface molecules 
capable of binding and sequestering hormones in an arranged spatial pattern (Bernfield 
et al., 1999).  Signaling molecules contain heparin binding domains within their 
structure that are capable of forming these extracellular signaling patterns (Ohkawara et 
al., 2002). 
 ECMs, in particular fibronectin (FN), are able to sequester signaling molecules to 
allow for gradient patterned presentations.  They are also responsible for the movement 
and guidance of cells during differentiation.  During Xenopus gastrulation, the basic 
body plan of the embryo is set up by the movement of the involuting cells from the 
dorsal lip along a pre-existing ECM (Ramos and DeSimone, 1996).  This movement, 
conducted over FN, allows for the spatial orientation of the different cell types.  It also 
allows for proper placement of cells that are capable of inducing differential tissue 
induction by releasing signaling molecules to the overlying cell layers.  An example of 
this is the movement of the dorso-mesodermal tissues ventrally underneath the 
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ectoderm, to set up the antagonistic interaction gradient of the organizer molecules with 
BMP for epidermal and neural induction (Delaune et al., 2005).  The use of FN in the 
interaction between BMP and its antagonists is a reason we have chose FN as our 
matrix for printing.  However, after preliminary results show no difference between 
using fibrin or FN, fibrin was used for the rest of the experiments.  
 Aside from trying to replicate what is happening in vivo, the solid-phase approach 
allows for more extensive testing of the signaling molecules present in a developmental 
model.  With liquid-phase assays, researchers were only able to test responses at a 
particular concentration.  If they were assessing different responses due to different 
concentrations, they had to perform multiple assays, and then gather the results to 
describe the response a tissue has over a range of different concentrations.  A solid-
phase approach will not be limited to using only one concentration or one signaling 
molecule for each assay.  With solid-phase signaling, we can set up concentration 
gradients to detect graded differentiation responses.  Along with concentration 
gradients, we can set up competition assays between two or more signaling molecules.  
In the liquid-phase assays, this idea of a competition assay could only be set up at a 
particular concentration and with little control over the interactions between the 
signaling molecules. 
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VIII. Plan of Thesis 
A. Rationale: 
 Cells become different in development due to induction, a ligand-mediated cell 
interaction.  The conventional approach to induction with Xenopus, employs placing 
cells in a growth factor solution.  This design misrepresents in vivo conditions.  Here, I 
propose solid-phase induction as a more realistic and controllable approach.  My 
objectives were: (1) To design a solid-phase induction chamber for presentation of 
growth factors, and (2) To inducing Xenopus animal caps to differentiate into 
mesoderm, via presentation of FGF-2 in solid-phase. 
B.  Experimental Approach: 
 I will present both the design of the solid-phase chamber as well as the results of 
solid-phase FGF-2 induction of Xenopus animal caps.  Multiple membranes and grids 
were tested until the optimal chamber was obtained.  Once the chamber was designed, 
Xenopus embryos were cultured to the desired stage of development, and animal caps 
were isolated.  These caps were placed into liquid-phase cultures with FGF-2 in 
solution or into solid-phase chambers with FGF-2 attached to glass slides.  Mesoderm 
gene expression was analyzed with RT-qPCR and in situ hybridization. 
 
 
 
 
 
 
 
 
 
 
 
 22 
Material and Methods 
 
I. Xenopus Embryos: 
 Sexually mature male and female frogs were purchased from Xenopus express 
(http://www.xenopus.com).  These animals were fed and maintained in a colony until 
fertilization.  Females were injected in their thigh, just under the skin with 0.05 ml 1 
unit/ul Gonadotropin from pregnant mares’ serum (PMS), as shown in Fig. 1, around 
6:00 pm to initiate the ovulation procedure and stored at room temperature (Sigma).  Two 
to three days later, the frogs were injected in the same place with 0.6 ml 10 units/ul 
Human Chorionic Gonadotropin (HCG) at 6:00 pm and placed in a 15oC incubator 
overnight (Sigma).  Between 9 and 10 am the next morning, the female was removed 
from the incubator and placed at room temperature for 30 min.  During this time a male 
frog was sacrificed and dissected to remove the testes.  The testes were placed in 200% 
Steinberg’s containing 1X gentamicin and stored at 4oC until needed.  Two ml of 80% 
Steinberg’s were placed in the center of a Petri dish and ¼ of a testis was minced to 
release the sperm.  The female was then gently squeezed to aid in the release of her eggs.  
This dish, containing the 80% Steinberg’s, sperm, and eggs, was gently swirled and left at 
room temperature for 5 min.   
 After this time, the Petri dish was flooded with 20% Steinberg’s and left at room 
temperature.  About 30-40 min post-fertilization, the solution was poured off and 
replaced with 2.5% L-cysteine HCl, pH 7.8, and continuously swirled until the jelly layer 
was removed (≈ 5 min).  The embryos were washed 4-5 times with 20% Steinberg’s, 
being careful not to allow the embryos to come in contact with the air/water interface.  
The embryos were then transferred to a new Petri dish containing fresh 20% Steinberg’s 
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and allowed to develop at room temperature to stage 9 (newicop and fabor), Fig. 1, 
approximately 6 hours at 23oC.  Once the embryos reached late blastula, they were 
dissected.  
 
II. Animal cap isolation:  
 When the embryos reached stage 9, stage 8-10 for albino embryos, they are 
transferred to a Petri dish containing 100% Steinberg’s and 1X gentamicin for dissection.  
Dissections were performed with the Gastromaster (Xenotek Engineering) using the 
yellow platinum tip set at a cutting diameter of 750 um and on the high yellow setting.  
The use of this machine allows for fast and precise dissections without the need to 
remove the fertilization membrane.  Animal caps were isolated 12-15 at a time, and 
transferred with a plastic Pasteur pipette to a 6 well plate containing different 
concentrations of FGF-2 for liquid-phase induction or to the solid-phase chamber for 
solid-phase induction.  
 
III. Liquid-phase induction: 
 To induce the isolated animal caps to differentiate via liquid-phase induction, all 
that is needed is the tissue, a 6 well culture plate, and the growth factor, in this case FGF-
2.  The 6 well plates were filled with 5 ml of 20% Steinberg’s containing the desired 
concentration of FGF-2.  One control well was filled, with 20% Steinberg’s and no FGF-
2.  Once the plate was filled it was stored on ice while the isolation of the animal caps 
was being performed.  Twelve to fifteen animal caps were transferred to each well and 
placed on a nutator for 4 hours.  After 4 hours, the caps were transferred to individual 1.5 
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ml microcentrifuge tubes, which were submerged in liquid nitrogen.  Once all of the caps 
were collected and frozen, the tubes were stored at -80oC for later use.  
 
IV. Design of the solid-phase chamber: 
a. Fibrin slide preparation: 
Fibrin coated glass slides were prepared essentially as described by Miller et al. 
(Miller et al., 2006).  Glass slides were cut into 1 in. squares.  Glass was cleaned first 
with sulfuric ace and NOCHROMIX for 2 hours, rinse with deionized water ten times, 
and dried under nitrogen gas.  Glass was then incubated in 95% acetone containing 1% 3-
aminopropyltriethoxysilane (Gelest, Inc. Morrisville, PA) for ten min. at 230C to coat 
glass surface with amine groups.  Glass slides were then rinsed in acetone, ethanol, and 
deionized water respectively three times.   
Squares were then dried at 1200C for 45 min. and then incubated in a 3% 
glutaraldehyde solution (Electron Microscopy Sciences, Hatfield, PA) in phosphate 
buffered saline, pH 7.4, at 370C for 2 hours.  Squares were then rinsed twice with 
methanol and then twice with deionized water. 
Slides were then incubated in 0.1mg/ml fibrinogen (Aventis Behring, King of 
Prussia, PA) contained in 10 mM sodium phosphate buffer, pH 7.4 at 40C for 18 hours.  
Excess fibrinogen was removed by aspiration and then remaining active sites on the glass 
slide was blocked with 0.3 M glycine (Bio-Rad Laboratories, Hercules, CA), pH 7.4 at 
40C for 2 hours.  This was followed by 3 rinses with PBS.  The fibrinogen was then 
converted into fibrin by incubation with 4 U/ml thrombin (Aventis Behring, King of 
Prussia, PA) contained in 10 mM sodium phosphate buffer and 1 mM calcium chloride 
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for 2 hours at 370C.  Slides were then rinsed with sterile deionized water twice, and the 
air-dried in a laminar flow hood.  The thickness of the fibrin films was estimated to be 
approximately 20 nm, and it was verified that the glass slide was covered uniformly with 
a transmission and scanning electron microscope.  FN coated slides were prepared the 
same way with the FN added to the fibrin.   
b.  Solid-phase induction: 
The fibrin slides that were stored in PBS were transferred to fresh Petri dishes inside 
a sterile hood and washed twice with sterile water.  The slides were placed on a Kimwipe 
and allowed to dry for 30 min.  Once dry, a desired amount of FGF-2 was spotted onto 
the center of the slide and allowed to adhere and dry for 30-45 min.  After the FGF-2 was 
dry, the outline of the spot was scored with a diamond tip pen and the slide was placed in 
4oC submerged in 100% Steinberg’s at 4oC overnight.   
 A medium Petri dish (60 x 15 mm) was taken, and four corners of a 1 cm square 
were spotted with machine grease in the center of the Petri dish.  A 1 cm square of 
NYTRAN Plus paper was cut as well as a 1 cm square of stainless steel grid (DexMet; 
Brandford, Conn.).  Once everything was prepared, the fibrin slides were removed from 
the refrigerator and stored on ice until they were used.  The Petri dish was filled with 
20% Steinberg’s and the NYTRAN paper was placed under the grease spots.  Next the 
stainless steel grid was lowered on top of the grease spots and firmly pressed down with 
forceps.  Once the chamber was set up, the animal caps were isolated and transferred to 
the grid with a plastic Pasture pipette.  The animal caps were manipulated with fine 
forceps with the outer layer of cells lying on the NYTRAN paper.  Once 8-10 animal 
caps were centered in the grid, the fibrin slide was laid on top of the grid, fibrin side 
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down, with the FGF-2 centered over the animal caps.  To ensure good contact between 
the animal caps and the FGF-2, 5 mechanical washers (diameter 1 ½ cm) were taped 
together and lowered on top to the glass slide.  This setup was performed in 20% 
Steinberg’s.  The chamber was allowed to sit at room temperature for 4 hours at which 
time the animal caps were transferred to fresh 1.5 ml microfuge tubes.  A pipette was 
used to remove as much Steinberg’s as possible, without letting the animal caps come in 
contact with the air/water interface, and then the caps were submerged in liquid nitrogen.  
Once all caps were frozen, the microfuge tubes were transferred to -80o until later use.   
 
V. RNA extraction:  
 Once a sufficient number of animal caps were induced and collected for RT-
qPCR, RNA was extracted using the RNeasy Mini Kit (Qiagen).  Prior to isolation, 10 ul 
β-Mercaptoethanol (β-ME) was added per 1 ml Buffer RLT.  This solution was reused in 
subsequent extractions for up to 1 month.  Caps were removed from -80oC and 350 ul of 
β-ME + Buffer RLT was added, on ice, before samples thawed.  Samples were mixed by 
pipetting and transferred to a QIAshredder column (Qiagen), placed in a fresh 1.5 ml 
microcentrafuge tube.  The sample was centrifuged for 3 min, and the supernatant was 
transferred to a fresh 1.5 ml microcentrifuge tube, to which 350 ul of 70% ethanol was 
immediately added and mixed with gentle pipetting.  The sample was transferred to an 
RNeasy mini column (Qiagen) that was placed into a 2 ml collection tube, and 
centrifuged for 15 sec.  The flow-through was discarded and 700 ul of buffer RW1 was 
added to the RNeasy column and centrifuged for 15 sec.  Once again the flow-through 
was discarded and the RNeasy mini column was transferred to a fresh 2 ml collection 
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tube.  Next, 500 ul of buffer RPE was added to the column and centrifuged for 15 sec, 
discarding the flow-through.  This step was repeated again, but the sample was 
centrifuged for 2 min.  The dry RNeasy mini column was transferred to a fresh 1.5 ml 
microcentrifuge tube where 30 ul RNase-free water (MP Biomedicals: Irvine, CA) was 
added directly to the membrane and centrifuged for 1 min.  The flow through now 
contains the purified RNA which was then stored at -80oC for later use.   
 
VI. RT-qPCR: 
a. 1 step RT-qPCR amplification: 
 After RNA extraction, real-time RT-qPCR reactions were performed using One-
Step Taqman® RT-PCR Master Mix, primers and probes (Applied Biosystems: Foster 
City, CA. and IDT).  The Xenopus primer and probe sequences were as follows: Xbra. 
forward- 5’ CAC CTC ACT ACT CGT CTC TTT CAC A 3’(IDT# 17959291), reverse- 
5’ TGC TCC ATG CTC ATA CAA TGG 3’(IDT# 17959292),  probe- 5’ TGT GCC 
CTC ACC ATC CAC AGG ATC 3’ (IDT# 17959294); Xwnt-8. forward- 5’ GCT ACC 
CAC AAT GGA CTT CGA 3’, reverse- 5’ AAC TCC CGC TGA GCT AAT GG 3’, 
probe- 5’ TGC AAC CAG AGA AAC CTC CTT TGT; 18S primers and probes were 
designed by Applied Biosystems (Foster City, CA) and the sequences were not given.  
The 18S primers and probes were designed for human DNA amplification but could be 
used for Xenopus as well, as stated by Applied Biosystems (Foster City, CA).  Both Xbra 
and Xwnt-8 probes were labeled with a 5’ FAM reporter dye and a 3’ TAMRA quencher 
dye.  The 18S probe was labeled with a 5’ VIC reporter dye and a 3’ TAMRA quencher 
dye.   
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 Two ul of RNA sample was used per 10 ul reaction with One-Step Taqman  RT-
PCR Master Mix (Applied Biosystems: Foster City, CA), sequence specific primers 
(50nM), and Taqman  Probes (100nM).  A master mixture of all components except for 
the RNA was added together with the following components per sample of RNA: 24 ul 
Taqman One-Step Master Mix (2X), 18.96 ul RNase free water, 0.96 ul Forward primer 
(10 uM), 0.96 ul Reverse primer (10 uM), 0.96 ul Probe (5uM), 1.2 ul RT/RNase 
Inhibitor (40X), and a total volume of 48 ul was reached with RNase free water.  From 
this master mix, 38 ul was removed and put into a new microfuge tube to which 2 ul of 
sample RNA was added.  The tube was vortex and 10 ul was removed and dispensed into 
a well of the PCR plate.  Real-time RT-qPCR assays were carried out in triplicate using 
an ABI Prism 7900 Sequence Detection System (AME Bioscience).  The thermocycling 
conditions were as follows; 48oC for 30 min (reverse transcription), 95oC for 10 min 
(initial denaturation) followed by 40 cycles at 95oC for 15 sec (denaturation) and 60oC for 
45 sec (annealing and extension).   
 
b. Separation and analysis of data: 
 Once the real-time RT-qPCR reactions were complete, the data was analyzed by 
using the sequence detection system (SDS) program version 2.1.  The threshold was set 
above the non-template control within the linear phase of the target gene amplification to 
calculate the cycle number at which the transcript is detected (CT).  The ribosomal gene 
18S was used as the reference to normalize the target gene expression.  Validation 
experiments conducted previously demonstrated that efficiencies of target genes and 
reference genes were approximately equal with the absolute value of the slope of log 
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input amounts vs. ∆CT<0.1 (J. Jowdlic, Carnegie Mellon University).  Total RNA in each 
sample was determined by the ∆CT values of the control groups (18S).  To be able to 
calculate the fold differences of the target genes (Xbra and Xwnt-8) from the controls 
(18S), the comparative ∆∆CT method was used as detailed in Applied Biosystems 
Bulletin #2 (37).  For this analysis cycle numbers not detected were set at 40 cycles, the 
maximum cycle number, to allow for statistical analysis.  Once the data was collected, it 
was entered into an excel document and used to produce the graphs seen in the results.  
 
VII. In situ hybridization of animal caps: 
a. Fixing caps for in situ: 
In addition to RT-qPCR, in situ hybridization was used to examine Xbra expression 
in animal caps.  Animal caps were dissected and induced/non-induced as described 
before and then transferred to a 5ml glass vial containing MEMFA.  This fixative was 
prepared fresh each time and consists of 100 mM MOPS pH 7.0, 2 mM EGTA, 1 mM 
MgSO4 and 3.7% formaldehyde.  The vials were completely filled with MEMFA, and the 
animal caps were rocked horizontally on a nutator.  After three hours, the vials were 
filled with fresh MEMFA and rocked horizontally for one hour.  The vials were then 
filled with 100% ethanol, and rocked for five min.  The ethanol was changed, and the 
vials were stored at -20oC until further use.   
b. Xbra Plasmid Midi Prep:   
 A glycerol stock of Xbra plasmid was thawed on ice and then aseptically streaked 
onto a fresh LB/ampr agarose plate.  The plate was placed in a 37oC incubator overnight.  
One colony was removed from the plate and placed into a fresh 70 ml beaker containing 
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50 ml LB/ampr liquid agarose.  The beaker was sealed with aluminum foil and placed in a 
shaking incubator at 37oC overnight.  Fifty ml of the culture was transferred to a 50 ml 
polypropylene centrifuge tube and spun for 20 min at room temperature.  Supernatant 
was discarded carefully so as not to disturb the pellet.  The pellet was completely re-
suspended in 4 ml of ice cold solution 1 (Eppendorf) and incubated at room temperature 
for 10 min, and on ice for an additional 5 min.  Solution 2 was added, and the tube was 
mixed by inversion to lyse the bacteria and placed on ice for 5 min.  After lysis, 4 ml of 
solution 3 was added.  The tube was mixed by inversion, incubated on ice for 10 min and 
centrifuged for 25 min.  The supernatant was removed carefully, without disturbing the 
pellet, and transferred to a fresh 50 ml centrifuge tube.  To this solution, 10 ul of cold 
DNA Binding Matrix (Eppendorf) was added and mixed vigorously by vortexing.  A spin 
column (Eppendorf) was placed into a fresh 50 ml centrifuge tube to which the solution 
was added and centrifuged for 10 min.  The filtrate was discarded; and the remaining 
“cake” on the spin column was washed twice with the Purification mix (Eppendorf) by 
centrifugation for 5 min.  After the second wash, the spin column was left at room 
temperature for 5 min to dry.  Three ml of DEPC-water was added, and the tube was 
centrifuged for 5 min to remove the purified plasmid.  A good yield was shown through 
spectrophotometry, and aliquots were distributed into 1.5 ml microcentrifuge tubes. 
c. Restriction digest of Xbra Plasmid: 
 The digestion reaction was prepared by adding 10 ug of plasmid DNA, 20 ul 
restriction buffer, 10 ul restriction enzyme and DEPC-water to a final volume of 200 ul.  
This solution was incubated in a 37oC water bath for 4 hours.  To terminate the reaction, 
3 ul of 1 mg/ml proteinase K and 10 ul SDS were added and incubated in a 55oC water 
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bath for 45 min.  Equal volumes of phenol: chloroform were added and vortexed to 
ensure absolute mixing of the solution.  After centrifugation for 10 min, the top layer was 
carefully removed and transferred to a new microcentrifuge tube.  An equal volume of 
chloroform was added to the mixture and centrifuged for 10 min.  The top layer was once 
again carefully removed and transferred to a new microfuge tube.  To the top layer, 20 ul 
3M sodium acetate pH 5.2 and 500 ul ice cold 100% ethanol were added and left at -20oC 
overnight.  The next day, the solution was centrifuged for 10 min, and the supernatant 
was discarded.  The pellet was then washed twice with 70% ethanol.   After the final 
wash, the pellet was allowed to air dry at room temperature for 25 min.  Once the pellet 
was dry, it was re-suspended in DEPC-water and quantified with spectrophotometry.  If 
the pellet did not re-suspend, the microfuge tubes were placed in a hot plate at 75oC for 5 
min to aid in the re-suspension.  The final suspension was stored at -20oC for later use.   
d. Transcription of the sense and antisense probes: 
 The digested plasmid was used as the template for transcription of the sense and 
antisense probes.  The transcription reaction was prepared at room temperature in a 1.5 
ml microcentrifuge tube in the following order: 4 ul 5X transcription buffer, 2 ul 2X DIG 
RNA labeling mix (Roche: Indianapolis, IN), 1 ul 100mM DTT (Fisher), 1 ul RNAse 
inhibitor (Takara: Madison, WI), 2 ul RNA polemerase SP6 for the sense strand 
(Invitrogen), or T7 (Fisher) for the antisense strand, 2 ug template, and DEPC-water to a 
final volume of 20ul.  The mixture was incubated in a hybridization oven at 37oC for 3 
hours.  Once the reaction was complete, 1 ul was removed and run on an ethidium 
bromide gel to check for proper transcription.  An equal volume of 8M LiCl was added to 
the rest of the reaction and stored overnight at -20oC.  The next morning the solution was 
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centrifuged for 10 min, and the supernatant was discarded.  The pellet was washed with 
70% ethanol and allowed to air dry for 25 min.  Once dry, the pellet was re-suspended in 
100 ul DEPC-water and quantified with spectrophotometry.  The transcript was 
hydrolyzed by adding 100 ul 80 mM sodium bicarbonate and 100 ul 120 mM sodium 
carbonate and incubating in a hybridization oven at 60oC for 30 min.  After incubation 
was complete, 12.5 ul 8M LiCl and 500 ul 100% ethanol was added and placed at -20oC 
overnight.  The solution was centrifuged for 5 min, and the pellet was washed twice with 
70% ethanol and allowed to air dry for 25 min.  The pellet was re-suspended in 
hybridization buffer and the amount of remaining probe was approximated by using the 
spectrophotometry reading taken just before hydrolysis.   
e. In situ hybridization: 
 Animal caps that were fixed in MEMFA were transferred to fresh 5 ml glass vials 
filled with 100% ethanol for in situ hybridization.  All subsequent washes and transfers 
were performed with plastic Pasteur pipettes.  Each in situ procedure was carried out in 
four vials of animal caps, each with 3-4 animal caps: 1) animal caps treated with 100 ng 
FGF-2 and subjected to the antisense probe, 2) animal caps treated with 100 ng FGF-2 
and subjected to the sense probe, 3) animal caps cultured in the solid-phase chamber 
without FGF-2 subjected to the antisense probe, 4) animal caps cultured in the solid-
phase chamber without FGF-2 subjected to the sense probe.  The vials went through an 
initial re-hydration procedure with the following washes performed in order: 100% 
ethanol, 75% ethanol + 25% DEPC-water, 50% ethanol + 50% DEPC-water, 25% 
ethanol +75% PTw (1X PBS + 0.1% tween-20 (Fisher)), and 100% PTw for 5 min each 
while rocking on a nutator vertically.  All subsequent washes were performed at room 
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temperature while rocking the vials vertically on a nutator unless stated otherwise.  After 
re-hydration, caps were washed three times in 100% PTw for 5 min.  The solution was 
replaced with 1 ml of 10 ug/ml proteinase K and incubated for 10 min.  The caps were 
washed twice with 5 ml 0.1 M triethanolamine pH 7.5 for 5 min each.  To the second 
wash 12.5 ul acetic anhydride (Sigma) was added and incubated for 5 min at which time 
an additional 12.5 ul acetic anhydride was add for 5 more min.  Caps were washed three 
times in 100% PTw for 5 min each and refixed in 4% paraformaldehyde for 20 min.  
Stock 20% paraformaldehyde was prepared in H2O and the cloudiness was neutralized 
with NaOH while mixing on a hot plate at 65oC.  Mixing was ceased after solution was 
clear, and the solution was covered in foil and stored at 4oC.  Once fixed, the caps were 
washed three times in 100% PTw for 5 min each.  All but one ml of the PTw was 
removed and 250 ul of hybridization buffer was added and allowed to settle to the bottom 
of the vials for 5 min.  This was replaced with 500 ul of fresh hybridization buffer and 
incubated in a hybridization oven for 10 min at 60oC.  The solution was once again 
replaced with a fresh 500 ul hybridization buffer and incubated at 60oC in the 
hybridization oven for 4 hours for pre-hybridization.  After pre-hybridization, the 
solution was replaced by 500 ul of fresh hybridization buffer containing 1 ug/ml of either 
the sense or antisense probe and incubated overnight in the hybridization oven at 60oC.  
The next day the caps were washed for 10 min with 500 ul fresh hybridization buffer at 
60oC in the hybridization oven.  Three successive washes were performed with 2X SSC 
for 20 min each at 60oC in the hybridization oven.  Caps were RNAse treated with a wash 
containing 5 ml of 2X SSC with 20 ug/ml RNAse A (Sigma) and 10 units/ml RNAse T1 
(Sigma) for 30 min at 37oC in the hybridization oven.  The RNAse treatment was 
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followed with two washes with 0.2X SSC for 30 min each at 60oC in the hybridization 
oven.  This solution was replaced with Maleic acid buffer (MAB: 100 mM Maleic acid, 
150 mM NaCl, pH 7.5) twice for 5 min each at room temperature.  The caps were washed 
with 2% Boehringer Blocking reagent (BMB, Roche) in MAB for one hour at room 
temperature.  This solution was replaced with 500 ul MAB + 2% BMB + 20% heat 
treated lamb serum (Gibco) for one hour at room temperature.  Antibody addition was 
performed by adding 500 ul fresh MAB + 2% BMB + 20% heat treated lamb serum and 
0.25ul antidigoxigenin antibody coupled to alkaline phosphatase (Roche) and incubated 
at room temperature for 4 hours.  After incubation, any unbound antibody was washed 
away five times, for one hour each, with fresh MAB.  One of these washes was 
performed overnight at 4oC.  To prepare the caps for visualization of the chromogenic 
reaction, they were washed in 5 ml of freshly made alkaline phosphatase buffer (100 mM 
Tris, pH 9.5, 50 mM MgCl2, 100 mM NaCl) twice for 5 min each.  This solution was 
replaced with 500 ul BM purple staining reagent (Roche) and rocked vertically in a 
closed box on a nutator until sufficient staining could be seen.  Staining was checked 
either by viewing through the glass vials or by transferring the caps into a Petri dish 
containing fresh alkaline phosphatase buffer.  The BM purple staining reagent was 
replaced if precipitate was forming.  Times for sufficient staining ranged from 3 ½ hours 
to 4 ½ hours during these experiments.  Once satisfied with the staining, the caps were 
fixed in MEMFA for 3 hours, followed by two washes in 100% ethanol.  Caps were 
transferred to Petri dishes containing 100% ethanol for photography, and stored in 100% 
ethanol at -20oC. 
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f. Photography of animal caps: 
 Once the in situ procedure was complete the caps were transferred to Petri dishes 
containing 100% ethanol.  Sense and antisense stained caps were photographed with a 
digital camera (Q-imaging Corporation) attached to a dissecting microscope.  Caps were 
carefully manipulated and moved with a fine hair loop while always keeping the caps 
submerged in the 100% ethanol.  Pictures were taken with a red transparent film 
underneath the Petri dishes for better contrast.  All pictures were formatted with Adobe 
Photoshop.   
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Results 
 
I. Liquid-phase FGF-2 induction: 
Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was used to detect 
Xbra transcripts in FGF-2 induced Xenopus laevis animal caps.  Primers were designed 
using Primer Design 2.0.  A set of primers forward and reverse were returned of which 
one forward and one reverse primer were picked to amplify the transcript as indicated in 
Material and Methods.  EF1-α, which is expressed throughout the embryo as a 
“housekeeper” gene, was used as a positive control for the RT-PCR reactions.  A band 
was expected when using the EF1-α primers to indicate good cDNA synthesis from the 
total RNA extracted (Fig.4).  A negative control was also included, not indicated in the 
figures, where RNA was used as the template with the EF1-α primers instead of cDNA.   
Xbra was expressed in whole embryos as well as was animal caps that were induced 
with FGF-2 (Fig. 4).  Animal caps that were isolated at the same stage but cultured in 
20% Steinberg’s showed no Xbra expression (Fig. 4).  
 
II. Solid-phase chamber design: 
The design of the solid-phase chamber entailed a few requirements for proper 
presentation of the growth factors to the isolated animal caps.  The animal caps had to 
remain flat to allow the inner cells to be exposed to the solid-phase growth factors.  The 
caps had to also be secluded from one another to inhibit signaling from one cap to the 
other.   
Isolated animal caps heal around themselves once removed from the embryo. What 
this means is the outside of the cap acts as a wound that heals rapidly by rounding up into 
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a sphere, with the outer surface of the cap enveloping the inner cells (Kofron 2002).   A 
method had to be employed to control the movements of these animal caps to allow for 
induction.  Different types of nitrocellulose papers and membranes were tested for 
adherence of the pigmented outer layer of the isolated animal caps.  Isolated animal caps 
from late blastula embryos were healed 30 min post-dissection in the absence of 
NYTRAN paper (Fig. 5A).  This is shown by the pigmented outer layer completely 
enveloping the cap (Fig. 5A).  Isolated animal caps, also from late blastula embryos, that 
were placed pigmented side down onto NYTRAN Plus nitrocellulose paper showed no 
evidence of healing with the inner cells remaining exposed to the surrounding solution 45 
min post-dissection (Fig. 5B).   
Once the healing of the animal caps was inhibited, the next step was to isolate the 
individual caps from one another, and control the contact of the solid-phase glass slide.  
The rest of the chamber provided this control by utilizing a stainless steel grid, 700 um in 
pore diameter and 100 um in depth (Fig. 6A+B).  The third component of the chamber 
was the Fibrin coated glass slide.  The slide was the site for FGF-2 attachment, and was 
placed directly on top of the stainless steel grid (Fig. 6B).  The final component of the 
solid-phase chamber was a set of washers taped together, and placed onto the glass slide 
for added weight (Fig. 6C). 
 
III. Establishing an RT-qPCR assay for transcript detection: 
Solid-phase induction of animal caps was assayed by employing RT-qPCR to 
quantitatively detect levels of Xbra expression.  Xbra primers and probes were designed 
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using Primer Design 2.0 as stated in Material and Methods.  18S human primers and 
probes (Applied Biosystems) were used as directed by ABI.   
18S is expressed throughout the embryo, and is used in RT-qPCR experiments as the 
control for RNA detection as well as a control to normalize the amount of experimental 
transcript present.   
 
IV. RT-qPCR detection of Xbra in liquid-phase and solid-phase FGF-2 
induction: 
Xbra expression was detected in RT-PCR of liquid phase FGF-2 induction so it was 
important that this same result could be shown employing the new method, RT-qPCR.  
The results indicated that with increasing concentrations of FGF-2, there was an increase 
in Xbra expression (Fig. 7A).  In the absence of FGF-2, there was no expression of Xbra 
(Fig. 7A).   
Solid-phase induction was initiated by isolating stage 9 (Newikop and Faber) animal 
caps and exposing them to the solid-phase FGF-2 for four hours to allow for mesoderm 
induction.  The concentrations used were determined by the results seen with MG-63 
cells (Campbell 2005).  The results indicate an increase in Xbra expression in relation to 
an increase in FGF-2 presented to the animal caps in the Solid-phase chamber (Fig. 
7B,C,D).  In the solid-phase induction experiments there were two negative controls used 
per RT-qPCR run.  The first control was the placement of the animal caps in 20% 
Steinberg’s without the presence of FGF-2 or the solid-phase chamber.  The second 
control was also in the absence of FGF-2 but caps were cultured in the Solid-phase 
chamber to simulate the mechanical stress induced by being in the chamber.  In all of the 
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experiments performed there was little or no expression of Xbra in both of the negative 
controls (Fig. 7).   
Each one of the points represented on the graph indicates a single RNA sample 
extracted from 6-8 animal caps that came from the same female and were induced in the 
same solid-phase chamber separate from all other samples.  Each graph represents 
separate RT-qPCR experiments performed with different RNA, master mixes, and in a 
different 384 well plate.  Although they each individually showed quantitatively different 
results, they all showed the same trend of increasing Xbra expression with an increase of 
FGF-2 presented.   
The values represented on the graph for the solid-phase FGF-2 induction represent the 
mass amount of FGF-2 applied to the Fibrin coated glass slide.  Each animal cap had a 
surface area of  384,845.1 µm2, the 5ng, 50ng mass amount used a 5ul spot of FGF-2 
which had a suface area of 7,068,583.5 µm2 and, the 10ng, 100ng mass amount used a 
10ul spot of FGF-2 which had a suface area of 12,566,370.6 µm2.  Using a ratio of these 
surface areas, the approximate mass amount of FGF-2 presented to each animal cap at 
5ng was .27ng, at 10ng was .31ng, at 50ng was 2.7ng, and at 100ng was 3.1ng. 
 
V. In situ hybridization of animal caps induced with FGF-2: 
In situ hybridization was performed on the animal caps to confirm the results seen 
with RT-qPCR and to visualize any pattern of Xbra expression.  Animal caps were 
grouped into 4 different categories: 
1) FGF-2 induced animal caps with the antisense probe  
2) FGF-2 induced animal caps with the sense probe  
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3) Non-induced animal caps with the antisense probe  
4) Non-induced animal caps with the sense probe 
Three experiments were performed with two independently synthesized sense and 
antisense probes.  They were also performed on different batches of animal caps from 
embryos originating from different females and males.  Two of the three experiments 
showed similar staining patterns (Fig. 8A+B), while the third showed no staining (not 
shown).  The lack of staining in the third experiment was due to the inability to continue 
the staining step to completion.   
 In both experiments, all seven animal caps that were induced with FGF-2 and 
exposed to the antisense probe showed staining throughout the animal caps (Fig. 8A,B) 
 Conversely, in both experiments all seven animal caps that were induced with 
FGF-2 and exposed to the sense probe exhibited no staining (Fig. 8A,B).  Also, in both 
experiments all six of the animal caps that were not induced with FGF-2 and exposed to 
the antisense probe showed no staining (Fig. 8A,B).  In both experiments all five animal 
caps that were not induced with FGF-2 and exposed to the sense probe showed no 
staining (not shown).   
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Fig. 3: Animal cap isolation 
Xenopus embryos were allowed to develop to late blastula-early gastrula, stage 9.  At this point 
the animal cap was excised with the Gastromaster dissection tool as indicated. 
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Fig. 4: Expression of the mesoderm marker Xbra in response to FGF-2 in liquid-phase.  
Three cDNA samples were analyzed: 1) animal caps treated with FGF-2 at 10 mg/ml (+), whole 
embryos (w), and untreated animal caps (-).  The top six lanes represent RT-PCR with primers 
for the constitutively expressed gene EF1- α, the bottom six lanes represent RT-PCR with 
primers for the mesoderm marker Xbra.  Experiments were done in duplicates. 
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Fig. 5: Inhibition of animal cap healing 
ealing. The outer pigmented cell layer migrates around 
t are 
 
(A) Isolated animal caps undergo wound h
the inner cells forming a sphere, isolating the inner cell from the surrounding media.  This 
process will take place within 20 min post-dissection (Bar = 200 um).  (B) Animal caps tha
placed, pigmented side down, on NYTRAN nitrocellulose paper remain un-healed 45 min post-
dissection (Bar = 700 um) 
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Fig. 6:  Solid-phase chamber design 
design was 100um thick and the pore openings had a 
ch 
 
(A) The stainless steel grid used in this 
width of 700um as indicated.  (B) This grid was laid onto the nitrocellulose membrane, at whi
time the animal caps were placed into the openings.  The glass slide containing the solid-phase 
FGF-2 was then placed on top.  (C) The final component of the chamber, the washers, added the
necessary weight to maintain the contact between the glass slide and the animal caps.  
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Fig. 7: Xbra expression in response to FGF-2, presented in liquid-phase or solid-phase 
ld 
sponse 
e 
.  
 
Each point on the graph indicates a single RNA sample extracted from 6-8 animal caps from the 
same female.  In the solid-phase cases (B,C,D), the 6-8 caps were induced in the same solid-
phase chamber separate from all other samples.  Each graph represents a separate RT-qPCR 
experiment performed with different RNA, master mixes, and 384 well plate.  (A) The log fo
expression of Xbra over the control in response to liquid-phase presentation of different 
concentrations of FGF-2.  (B,C,D) The log fold expression of Xbra over the control in re
to solid-phase presentation of different concentrations of FGF-2.  (-) control represents animal 
caps cultured in 20% Steinberg’s with no FGF-2.  0ng/ul:5ul represents the second control wher
animal caps were cultured in the solid-phase chamber in the absence of FGF-2.  The values 
indicated on the graph represent the mass amount of FGF-2 applied to the Fibrin coated slide
The approximate amount of FGF-2 presented to each animal cap for each mass amount used is 
shown in the results text.   
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Fig. 8: In situ of animal caps exposed to FGF-2  
(A) In situ hybridization was performed with sense and antisense Xbra probes on animal caps 
that were treated with solid-phase FGF-2 and animal caps that were untreated.  The untreated 
caps were allowed to develop for the same amount of time as the treated caps inside the solid-
phase chamber.  (a) Animal caps that were treated with solid-phase FGF-2 and incubated with 
the Xbra antisense probe showed dark staining throughout the cap (FGF Antisense).  As 
expected, caps that were treated with solid-phase FGF-2 and incubated with the Xbra sense 
probe showed no staining (FGF Sense).  (b) Animal caps that were left untreated and incubated 
with the Xbra antisense probe showed no staining (Untreated Antisense).  (B) In situ experiment 
two.  Same results seen as in A but with lighter staining.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 52 
 
 
 
 
 
 
 
 
 
 
 
B 
 
a 
 
Fig. 8A 
 
 
 
 
 
 
 
 
 
 
 53 
 
 
 
 
 
 
 
 
 
 
 
A 
 
B 
 
Fig. 8B 
 
 
 
 
 
 
 
 
 
 
 
 
 54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9: New solid-phase chamber design 
The new solid-phase chamber is composed of de-ionized aluminum.  (A) The dimensions of the 
grid will be the same as in figure 7 with a thickness of 100 um and the pore width being 700 um.  
The grid insert contains 16 pores for animal cap placement, as well as grooves cut on the 
underside to allow for exposure of the caps to oxygen.  (B) The chamber will utilize two screws 
for correct placement of the solid-phase growth factor containing glass slide.  These screws will 
also apply the correct weight necessary for constant contact between the glass slide and the 
animal caps (drawing not to scale).  
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Fig. 10:  Model for neural induction experiment 
(A) The two current, models for neural induction by the organizer tissue are indicated by the two 
drawings.  The vertical hypothesis states that as the organizer passes underneath the ectoderm the 
vertical release of the inhibitor molecules induce neural tissue.  On the other hand, the horizontal 
hypothesis states that there is a single, initial release of inhibitor molecules at the dorsal lip that 
propagates through the ectoderm.  (B) This can be directly tested with the application of the 
solid-phase approach, and the printed pattern of noggin indicated.  (C) The two possible results 
that would be expected after performing in situ on the animal caps, in relation to the type of 
induction taking place are as indicated.  If the vertical mode is correct, the staining should only 
be present where the animal cap was in contact with the noggin.  If the horizontal mode is 
correct, a diffuse staining should be seen within the contact area as well as further around.    
(Fig. 10.7 from Gilbert, 2000 was used for this figure by permission from Sinauer Inc). 
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Discussion 
I. Liquid-phase induction with FGF-2: 
 Initial liquid-phase induction with FGF-2 shows expected results with RT-PCR 
analysis.  Animal caps that were cultured in the presence of FGF-2 in solution 
differentiated into mesoderm tissue as indicated by Xbra expression.  Animal caps that 
were cultured in the absence of FGF-2 in solution did not differentiate into mesoderm 
indicated by the absence of Xbra expression.  These results indicate that in the 
presence of FGF-2 animal caps will differentiate into mesoderm and express the 
mesoderm gene marker Xbra. Animal caps induced with liquid-phase FGF-2 showed a 
dose response in Xbra expression.  This expression seemed to plateau between 
10ng/ml and 100ng/ml of FGF-2 in solution.   
 
II. Solid-phase chamber design: 
 The solid-phase chamber consisted of four components: 1) Nitrocellulose paper, 
2) stainless steel grid, 3) solid-phase glass slide, and 4) stack of washers for weight.  
Each one of these components went though rigorous testing to determine the 
requirements for each component.  For the nitrocellulose, animal caps attached to 
NYTRAN paper the best out of the tested papers.  Animal caps usually heal into balls, 
but adhesion to the NYTRAN paper allowed the animal caps to remain unhealed for 
more than 45min.  This lack of healing was critical to allow the sensitive inner cells of 
the animal cap to be exposed to the solid-phase growth factors.   
 The second component, the stainless steel grid, was necessary for the precise 
placement of the animal caps and for isolation of each animal cap from one another.  
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The grid had to be thick enough to allow for the contact of the glass slide with the 
animal caps, while stopping the weight of the washers from crushing them.  The final 
dimensions of the grid were 100um thick and a pore size of 700um across.   
 The glass slide was coated with fibrin as described in Material and Methods to 
allow for the adhesion of FGF-2.  Miller et al. (2006) showed that there is little to no 
release of growth factor into the surrounding media after incubation of the fibrin 
coated glass slides containing FGF-2 for 24 hr in PBS.  Once the slides have been 
blotted with FGF-2 and incubated in PBS for 24 hours, little or no FGF-2 was released 
into the surrounding media after 150 hours of being seeded with human MG-63 cells 
(Miller 2006).  These results indicate that there was no soluble FGF-2, which would 
allow for liquid-phase exposure of the FGF-2. 
 The final component of the solid-phase chamber was five steel washers of one 
and a half inches in diameter.  This weight was sufficient to maintain the contact 
between the glass slide and the animal caps. 
 
III. Solid-phase induction with FGF-2: 
a. RT-qPCR of solid-phase FGF-2 induced animal caps: 
 In the first RT-qPCR experiment, the animal caps showed a dose response in Xbra 
expression to the different concentrations of solid-phase FGF-2 presented.  This is the 
first reported response of animal caps to the presentation of solid-phase FGF-2.  In 
both controls, animal caps cultured in 20% Steinberg’s and animal caps cultured in 
the solid-phase chamber in the absence of FGF-2, there was little or no expression of 
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Xbra.  This result indicates that the response was due to the presence of solid-phase 
FGF-2 and not to the induced stress of being contained in the solid-phase chamber.   
 The experiment was repeated two more times.  Both showed a dose response in 
Xbra expression to solid-phase FGF-2, as well as little or no expression of Xbra in 
either of the controls.  Although the amount of Xbra expression varied in each 
experiment, I conclude that animal caps presented with solid-phase FGF-2 are 
induced to differentiate into mesoderm in a dose dependent manor, as shown by Xbra 
expression.   
b. In situ examination of animal caps induced with solid-phase FGF-2: 
 In situ hybridization was performed with Xbra sense and antisense probes to 
assess further the response of animal caps to solid-phase FGF-2.  The in situ was also 
performed to visualize any possible spatial patterns of the response.  Animal caps 
were subjected to either induction via solid-phase FGF-2, or simply cultured in the 
solid-phase chamber in the absence of FGF-2.  This second experiment was 
performed as a control to see if there was any response induced by the solid-phase 
chamber itself.   
 Animal caps that were induced with solid-phase FGF-2 and exposed to the 
antisense Xbra probe showed vivid staining in comparison to untreated animal caps 
subjected to the same staining.  These results indicate that the animal caps that were 
induced with the solid-phase FGF-2 were responding with the expression of Xbra.  In 
both, the treated and untreated animal caps exposed to the sense Xbra probe, there 
was no response indicated by the lack of staining.   
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 This experiment was repeated giving the same results, although the levels of Xbra 
expression detected were lower.  The difference in the amount of staining in the two 
experiments could be due to a couple of factors: 1) the time allowed for staining was 
30 min less in the second experiment, 2) the animal caps were isolated from embryos 
of different frogs, or 3) the antisense probe used in each experiment was 
independently synthesized.  In conclusion, the results of the in situ experiments 
support the RT-qPCR results that animal caps presented with solid-phase FGF-2 
express Xbra, indicative of mesoderm induction. 
 
IV. New solid-phase chamber design:   
 To more efficiently use this novel method a new solid-phase chamber had to be 
designed using the acquired knowledge from the previous experiments.  The 
dimensions of the previously used grid have remained the same in the construction of 
the new grid.   The grid insert contains 16 pores for animal cap placement, as well as 
grooves cut on the underside to allow for constant transport of oxygen and other 
necessary nutrients to the isolated animal caps (Fig. 9A).  The chamber will utilize 
two screws for correct placement of the solid-phase growth factor containing glass 
slide.  These screws will also apply the correct weight necessary for constant contact 
between the glass slide and the animal caps (Fig. 9B).  The overall design will allow 
for printed patterns of growth factors to remain in registrar with the animal caps.   
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V. Future experiments with solid-phase growth factor presentation: 
 This novel approach to growth factor delivery can be applied to directly answer 
many development questions.  There are three questions dealing with neural induction 
that can be specifically answered: (1) the mode of neural induction, (2) the formation 
of boundry tissues during neural induction, and (3) differential neural differentiation 
in response to concentration gradients.    The first experiment that can be performed 
with this growth factor delivery approach is to determine the mode of neural 
induction.  In simple terms, neural induction takes place when the organizer tissue 
migrates during gastrulation, ventrally underneath the overlying ectoderm.  The two 
possible modes of induction are through the vertical release of the inhibitor molecules 
inducing neural tissue as it passes underneath the ectoderm, or a horizontal mode of 
induction with a single, initial release of inhibitor molecules at the dorsal lip (Fig. 
10A)(Gamse and Sive, 2000).  With solid-phase presentation, this experiment can be 
set up with animal caps, exposed to a simple pattern of noggin or another inhibitor 
molecule (Fig. 10B).  An in situ hybridization could then be performed with a neural 
marker to show the mode of inhibition.  If the natural induction process takes place 
via the vertical mode then you should only see a staining of the animal cap where the 
pattern of noggin was in direct contact with the cap (Fig. 10C).  While on the other 
hand if the natural mode of induction is the horizontal one, then you should see a 
diffuse staining through out the animal cap or at least in an area larger than the pattern 
of noggin (Fig. 10C) 
 During this same time boundary tissues are being formed between tissues that are 
expressing BMP and where BMP is being inhibited (Wardle and Sive, 2003).  This 
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question regarding boundary tissue formation has been looked at by manipulating the 
concentration of BMP and or the organizer molecules.  Also, experiments reporting 
cement gland specific gene expression between neural and epidermal tissue lead to 
the hypothesis of boundary tissue formation (Wardle and Sive, 2003).  Although these 
experiments have lead to a proposed hypothesis on boundary tissue formation, no 
definitive experiment has been done to show this.  Using the solid-phase approace, an 
experiment could be set up by printing a pattern where one half of the glass slide will 
be coated with noggin and the other half will be coated with BMP.  In situ 
hybridization could then be performed to see if the boundary tissue has formed 
between noggin and BMP induction.   
 Finally it has been proposed that during neural induction a concentration gradient 
is set up in the ectoderm by a gradient inhibition of BMP (Dale and Wardle, 1999).  
This inhibition is set up by the organizer releasing noggin along with other BMP 
binding proteins.  This gradient is hypothesized to be responsible for the dorsoventral 
patterning of the neural tissue (Dale and Wardle, 1999).  This question can be assayed 
with the solid-phase approach by printing a gradient pattern of noggin and exposing 
animal caps to this gradient.  In situ hybridization with different gene specific probes 
will give a visual representation of the response to this proposed gradient hypothesis.   
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Conclusion 
 This novel approach to growth factor presentation has a similar effect on 
differentiation as the current liquid-phase approach, providing developmental 
biologists with an additional technique to test the affects of growth factors during 
development.  This new approach will allow testing of patterns and multiple 
concentrations as well as multiple growth factors together.  This also mimics in vivo 
induction more accurately because during development cells are being presented 
these growth factors directly from surrounding cells or bound to the extracellular 
matrix. 
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